Abivax receives a "Strong Buy" rating, driven by positive phase 3 ABTECT induction data for obefazimod in moderate-to-severe ...

Genetic sharing among evolutionary neighbors all happens through hybrids: the offspring produced when individuals from two ...

According to management, statistical assessments of the Phase 3 trial points to a very high probability of technical success for regulatory approval of ateganosine. The U.S. Food and Drug ...

Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly ...

The latest insider buying arrives as ateganosine continues to deliver encouraging results. These outcomes have strengthened internal and external confidence that MAIA’s novel telomere-targeting ...

According to the official CBSE Board Exam 2026 datesheet, Physics will be conducted on February 20, Chemistry exam on ...

Merck’s Keytruda, the category-defining CPI, reported $29.5 billion in revenue in 2024, with NSCLC representing an estimated 30% of its total sales. Keytruda is expected to approach $35 billion by ...

We all face different obstacles, some more relentless than others. DEI is not about bringing one group down to boost another, and it certainly doesn’t hand out success. It’s about making sure talented ...

Projects involving the two Atlanta institutions have used technology to advance conservation efforts at Georgia Aquarium and ...

Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...

Though the BCSS attracts many science majors, its approach to coastal studies spans disciplines, from ecology and policy to ...

Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences ...